205 related articles for article (PubMed ID: 36908576)
1. The 11th Canadian Symposium on Hepatitis C Virus: 'Getting back on track towards hepatitis C elimination'.
Passos-Castilho AM; Udhesister STP; Fontaine G; Jeong D; Dickie M; Lund C; Russell R; Kronfli N
Can Liver J; 2023 Feb; 6(1):56-69. PubMed ID: 36908576
[TBL] [Abstract][Full Text] [Related]
2. The 9th Canadian Symposium on Hepatitis C Virus: Advances in HCV research and treatment towards elimination.
Li J; Casey JL; Greenwald ZR; Yasseen Iii AS; Dickie M; Feld JJ; Cooper CL; Crawley AM
Can Liver J; 2021; 4(1):59-71. PubMed ID: 35991475
[TBL] [Abstract][Full Text] [Related]
3. The 8
Cousineau SE; Erman A; Liu L; Saeed S; Fradette L; Feld JJ; Grebely J; MacParland SA; Shoukry NH; Sebastiani G; Sagan SM;
Can Liver J; 2020; 3(1):3-14. PubMed ID: 35992037
[TBL] [Abstract][Full Text] [Related]
4. The 7th Canadian Symposium on Hepatitis C Virus: "Toward Elimination of HCV: How to Get There".
Cheng ML; Abdel-Hakeem MS; Cousineau SE; Grebely J; Marshall AD; Saeed S; Sagan SM; Shoukry NH; Feld JJ; MacParland SA
Can Liver J; 2018; 1(3):139-152. PubMed ID: 35991324
[TBL] [Abstract][Full Text] [Related]
5. 6th Canadian Symposium on Hepatitis C Virus: Delivering a cure for hepatitis C infection-What are the remaining gaps?
Khan S; Bernier A; Dapp D; Fortier E; Krajden M; King A; Grebely J; Sagan SM; Cooper CL; Crawley AM
Can Liver J; 2018; 1(2):94-105. PubMed ID: 35990718
[TBL] [Abstract][Full Text] [Related]
6. The 5th Canadian Symposium on Hepatitis C Virus: We Are Not Done Yet-Remaining Challenges in Hepatitis C.
van Buuren N; Fradette L; Grebely J; King A; Krajden M; MacParland SA; Marshall A; Saeed S; Wilson J; Klein MB; Sagan SM
Can J Gastroenterol Hepatol; 2016; 2016():7603526. PubMed ID: 27843889
[TBL] [Abstract][Full Text] [Related]
7. Priorities and recommended actions for how researchers, practitioners, policy makers, and the affected community can work together to improve access to hepatitis C care for people who use drugs.
Day E; Broder T; Bruneau J; Cruse S; Dickie M; Fish S; Grillon C; Luhmann N; Mason K; McLean E; Trooskin S; Treloar C; Grebely J
Int J Drug Policy; 2019 Apr; 66():87-93. PubMed ID: 30743093
[TBL] [Abstract][Full Text] [Related]
8. Highlights of the Fourth Canadian Symposium on Hepatitis C: Moving towards a National Action Plan.
Sagan SM; Dupont B; Grebely J; Krajden M; MacParland SA; Raven JF; Saeed S; Feld JJ; Tyrrell DL; Wilson JA
Can J Gastroenterol Hepatol; 2016; 2016():5743521. PubMed ID: 27446849
[TBL] [Abstract][Full Text] [Related]
9. Gaps in hepatitis C virus prevention and care for HIV-hepatitis C virus co-infected people who inject drugs in Canada.
Lanièce Delaunay C; Maheu-Giroux M; Marathe G; Saeed S; Martel-Laferrière V; Cooper CL; Walmsley S; Cox J; Wong A; Klein MB;
Int J Drug Policy; 2022 May; 103():103627. PubMed ID: 35218989
[TBL] [Abstract][Full Text] [Related]
10. The role of prison-based interventions for hepatitis C virus (HCV) micro-elimination among people who inject drugs in Montréal, Canada.
Godin A; Kronfli N; Cox J; Alary M; Maheu-Giroux M
Int J Drug Policy; 2021 Feb; 88():102738. PubMed ID: 32278651
[TBL] [Abstract][Full Text] [Related]
11. The 3rd Canadian Symposium on Hepatitis C Virus: expanding care in the interferon-free era.
MacParland SA; Bilodeau M; Grebely J; Bruneau J; Cooper C; Klein M; Sagan S; Choucha N; Balfour L; Bialystok F; Krajden M; Raven J; Roberts E; Russell R; Houghton M; Tyrrell DL; Feld JJ;
Can J Gastroenterol Hepatol; 2014 Oct; 28(9):481-7. PubMed ID: 25314353
[TBL] [Abstract][Full Text] [Related]
12. Disparities in uptake of direct-acting antiviral therapy for hepatitis C among people who inject drugs in a Canadian setting.
Socías ME; Ti L; Wood E; Nosova E; Hull M; Hayashi K; Debeck K; Milloy MJ
Liver Int; 2019 Aug; 39(8):1400-1407. PubMed ID: 30653809
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C: The beginning of the end-key elements for successful European and national strategies to eliminate HCV in Europe.
Papatheodoridis GV; Hatzakis A; Cholongitas E; Baptista-Leite R; Baskozos I; Chhatwal J; Colombo M; Cortez-Pinto H; Craxi A; Goldberg D; Gore C; Kautz A; Lazarus JV; Mendão L; Peck-Radosavljevic M; Razavi H; Schatz E; Tözün N; van Damme P; Wedemeyer H; Yazdanpanah Y; Zuure F; Manns MP
J Viral Hepat; 2018 Mar; 25 Suppl 1():6-17. PubMed ID: 29508946
[TBL] [Abstract][Full Text] [Related]
14. Elimination of hepatitis C virus infection among people who use drugs: Ensuring equitable access to prevention, treatment, and care for all.
Grebely J; Hajarizadeh B; Lazarus JV; Bruneau J; Treloar C;
Int J Drug Policy; 2019 Oct; 72():1-10. PubMed ID: 31345644
[TBL] [Abstract][Full Text] [Related]
15. Impact of the COVID-19 pandemic on hepatitis B and C elimination: An EASL survey.
Kondili LA; Buti M; Riveiro-Barciela M; Maticic M; Negro F; Berg T; Craxì A
JHEP Rep; 2022 Sep; 4(9):100531. PubMed ID: 35967191
[TBL] [Abstract][Full Text] [Related]
16. NIH Consensus Statement on Management of Hepatitis C: 2002.
NIH Consens State Sci Statements; 2002 Jun 10-12; 19(3):1-46. PubMed ID: 14768714
[TBL] [Abstract][Full Text] [Related]
17. Reaching hepatitis C virus elimination targets requires health system interventions to enhance the care cascade.
Scott N; Doyle JS; Wilson DP; Wade A; Howell J; Pedrana A; Thompson A; Hellard ME
Int J Drug Policy; 2017 Sep; 47():107-116. PubMed ID: 28797497
[TBL] [Abstract][Full Text] [Related]
18. Disparities in direct acting antivirals uptake in HIV-hepatitis C co-infected populations in Canada.
Saeed S; Strumpf EC; Moodie EE; Young J; Nitulescu R; Cox J; Wong A; Walmsely S; Cooper C; Vachon ML; Martel-Laferriere V; Hull M; Conway B; Klein MB;
J Int AIDS Soc; 2017 Nov; 20(3):. PubMed ID: 29116684
[TBL] [Abstract][Full Text] [Related]
19. Liver health events: an indigenous community-led model to enhance HCV screening and linkage to care.
Pandey M; Konrad S; Reed N; Ahenakew V; Isbister P; Isbister T; Gallagher L; Campbell T; Skinner S
Health Promot Int; 2022 Feb; 37(1):. PubMed ID: 34125199
[TBL] [Abstract][Full Text] [Related]
20. Declining prevalence of current HCV infection and increased treatment uptake among people who inject drugs: The ETHOS Engage study.
Valerio H; Alavi M; Conway A; Silk D; Treloar C; Martinello M; Milat A; Dunlop A; Murray C; Henderson C; Amin J; Read P; Marks P; Degenhardt L; Stevens A; Prain B; Hayllar J; Reid D; Montebello M; Wade A; Christmass M; Cock V; Dore GJ; Grebely J;
Int J Drug Policy; 2022 Jul; 105():103706. PubMed ID: 35533635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
